Single-Cell Analysis Transcriptomics Market Report 2026

Single-Cell Analysis Transcriptomics Market Overview

• Single-Cell Analysis Transcriptomics market size has reached to $1.08 billion in 2025 • Expected to grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 12.2% • Growth Driver: The Increasing Adoption Of Personalized Medicine Is Fueling The Growth Of The Market Due To Its Ability To Enable Individualized Treatment Strategies • Market Trend: Advanced Launch Of Scale Biosciences Single Cell RNA Kit v1.1 Enhancing High-Throughput Transcriptomics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Single-Cell Analysis Transcriptomics Market?

Single-cell transcriptomics is a powerful technique for studying gene expression at the individual cell level. It identifies cellular heterogeneity and unique transcriptional profiles within complex tissues. Single-cell transcriptomics allows researchers to uncover cellular diversity, discover rare cell types, trace developmental lineages, and gain deeper insights into disease mechanisms. The main component types of single-cell analysis transcriptomics are equipment, consumables, software, and services. In single-cell transcriptomics, equipment enables precise RNA analysis at the individual cell level, advancing genomic research and personalized medicine. It utilizes various technologies such as single-cell ribonucleic acid (RNA) sequencing, microfluidics-based techniques, and others for several applications including clinical diagnostics, developmental biology, drug discovery, and others, and is used by various end-users such as academic and research institutions, hospitals and diagnostic centers, pharmaceutical and biotechnology companies.

What Is The Single-Cell Analysis Transcriptomics Market Growth Forecast?

The single-cell analysis transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to technological advancements in single-cell sequencing platforms, integration of cloud-based bioinformatics solutions, rising investment by pharmaceutical and biotechnology companies, increased adoption in personalized medicine, expansion of hospital and diagnostic center applications. Major trends in the forecast period include increasing adoption of single-cell rna sequencing techniques, rising use of microfluidics-based platforms, expansion of clinical diagnostics applications, growth in drug discovery and development research, enhanced data analysis and bioinformatics capabilities.

Global Single-Cell Analysis Transcriptomics Market Segmentation

1) By Component: Equipment, Consumables, Software And Services 2) By Technology: Single-Cell Ribonucleic Acid (RNA) Sequencing, Microfluidics-Based Techniques, Other Technologies 3) By Application: Clinical Diagonstics, Developmental Biology, Drug Discovery, Other Applications 4) By End-User: Academic And Research Institutions, Hospitals And Diagonstic Centers, Pharmaceutical And Biotechnology Companies Subsegments: 1) By Equipment: Ribonucleic Acid (RNA) Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Flow Cytometers, Imaging Systems 2) By Consumables: Reagents And Kits, Ribonucleic Acid (RNA) Extraction Kits, Microarray Chips, Sequencing Chips, Complementary DNA (cDNA) Synthesis Kits, Library Preparation Kits, Enzymes And Buffers 3) By Software And Services: Data Analysis Software, Transcriptome Assembly Software, Cloud-Based Solutions, Bioinformatics Services, Data Management Tools, Custom Analysis Services, Technical Support And Training

What Is The Driver Of The Single-Cell Analysis Transcriptomics Market?

The increasing adoption of personalized medicine is expected to propel the growth of the single-cell analysis transcriptomics market going forward. Personalized medicine is a medical approach that customizes treatment based on an individual’s genetic profile, lifestyle, and environment. The increasing adoption of personalized medicine is due to advances in genetic sequencing, enabling treatments tailored to individual genetic profiles for better effectiveness. Single-cell analysis transcriptomics uncovers individual gene expression profiles, guiding personalized treatments based on a patient’s unique biology. It enhances therapeutic effectiveness, minimizes side effects, and enables early disease diagnosis. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from 6 in 2022. Therefore, the increasing adoption of personalized medicine drives the growth of the single-cell analysis transcriptomics industry.

Key Players In The Global Single-Cell Analysis Transcriptomics Market

Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., CYTENA GmbH, Fluent BioSciences

Global Single-Cell Analysis Transcriptomics Market Trends and Insights

Major companies operating in the single cell analysis transcriptomics market are focusing on developing innovative products, such as single cell RNA sequencing kits, to streamline workflows and enable deeper insights into cellular heterogeneity. A single cell RNA sequencing kit is a specialized tool to isolate and analyze gene expression at the individual cell level. It allows researchers to uncover cellular diversity and gain insights into complex biological processes. For instance, in January 2024, Scale Biosciences, a US based biotechnology company specializing in single cell solutions, launched the Single Cell RNA Kit v1.1-Extended Throughput, enabling processing of up to 500,000 cells per run under an instrument free workflow. This release significantly enhances scaling, multiplexing, and cost efficiency in transcriptomic studies.

What Are Latest Mergers And Acquisitions In The Single-Cell Analysis Transcriptomics Market?

In May 2024, Bruker Corporation, a US-based manufacturer of scientific instruments, acquired NanoString Technologies for approximately $392.6 million. The acquisition aims to integrate NanoString’s gene expression profiling and spatial transcriptomics solutions into Bruker’s spatial biology portfolio. This move will create a highly complementary business, enhance Bruker’s discovery and translational research capabilities, and support ongoing innovation in single-cell and spatial biology. NanoString Technologies, Inc. is a US-based provider of single-cell transcriptomics solutions.

Regional Outlook

North America was the largest region in the single-cell analysis transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Single-Cell Analysis Transcriptomics Market?

The single-cell analysis transcriptomics market consists of revenues earned by entities by providing services such as data analysis and interpretation, sample preparation, and customized gene expression profiling solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The single-cell analysis transcriptomics market includes sales of RNA extraction kits, library preparation kits, cnd DNA synthesis kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.